Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Generation of a selectively cytotoxic fusion protein against p53 mutated cancers

  • Christina A Kousparou1, 2Email author,
  • Efthymia Yiacoumi1,
  • Mahendra P Deonarain2 and
  • Agamemnon A Epenetos1, 2
BMC Cancer201212:338

DOI: 10.1186/1471-2407-12-338

Received: 31 October 2011

Accepted: 18 July 2012

Published: 3 August 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
31 Oct 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
9 Dec 2011 Reviewed Reviewer Report - Piotr Widlak
10 Dec 2011 Reviewed Reviewer Report - Saeid Ghavami
6 Apr 2012 Author responded Author comments - Mahendra Deonarain
Resubmission - Version 3
6 Apr 2012 Submitted Manuscript version 3
11 Apr 2012 Reviewed Reviewer Report - Saeid Ghavami
26 Apr 2012 Reviewed Reviewer Report - Piotr Widlak
27 May 2012 Author responded Author comments - Mahendra Deonarain
Resubmission - Version 4
27 May 2012 Submitted Manuscript version 4
3 Jul 2012 Author responded Author comments - Mahendra Deonarain
Resubmission - Version 5
3 Jul 2012 Submitted Manuscript version 5
Publishing
18 Jul 2012 Editorially accepted
3 Aug 2012 Article published 10.1186/1471-2407-12-338

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Trojantec Ltd, The Bank of Cyprus Oncology Centre
(2)
Imperial College London

Advertisement